Hip Replacement Market - By Product (Partial Hip Replacement, Revision Hip Replacement, Hip Resurfacing), By Material (Metal-on-plastic, Ceramic-on-ceramic, Ceramic-on-metal), By Fixation Material (Cemented, Cementless, Hybrid), By Inserts, End-use - Global Forecast to 2032

Industry Statistics

Hip Replacement Market size exceeded USD 7.5 billion in 2022 and is forecast to register around 3.5% CAGR between 2023 and 2032. Increasing number of road accidents and hip injuries across the world is fueling the industry growth. The surge in the number of hip arthroplasty procedures is accelerating the acceptance of hip replacement devices.
 

To get more details on this report: Request Free Sample PDF
 

Hip replacement devices or implants are medical devices used to recover mobility and reduce pain associated with arthritis and other hip disorders. Each hip implant system has different device design features such as material, shape, fixation materials, etc. The adoption of hip replacement surgery is increasing due to its high success and low complication rate. Many hip replacements last for about 15 years based on material, manufacturer, and types of joint replacement.
 

However, the hip replacement devices are classified as a Class III medical device that is subject to stringent regulations and compliances. As a result, these devices are regulated by the U.S. FDA. A premarket approval (PMA) is needed for class III devices before their commercial distribution. The manufacturer is required to get approval under section 515 of the act that comprises of FDA's issuance of approving the application for premarket approval (PMA) for the device. Moreover, the European Union Commission has revised the medical device regulation that substitutes the current medical device directive. As per the new regulation, these devices are classified as class 3 devices that refer to a class of high-risk devices that are subject to stringent compliances. Hence, stringent regulations will impede the hip replacement market growth in the future.
 

Recent technological advancements will stimulate the market growth

Rising technological developments across the world will stimulate the market expansion. Recent innovations in surgical technique and instrumentation enables the surgeons to perform hip replacement procedures through smaller incision on the skin. This facilitates quicker recovery and faster rehabilitation. Furthermore, recently developed Hana Table, a unique patient positioning tool facilitates early recovery for hip replacement patients. This table aids secure the patient during surgery, makes exposure of the hip joint easier, and enables proper implant positioning. Similarly, the advent of custom implants has been beneficial for healthcare providers as well as patients. Custom implants are tailored as per patient requirements and provide better fitting, broader ranges of movement and higher satisfaction. Industry players are emphasizing on research and development activities to offer advanced products with better effectiveness.
 

Growing adoption of primary hip replacement devices will fuel the market statistics

To get more details on this report: Request Free Sample PDF
 

The primary hip replacement devices segment held more than USD 5.49 billion in 2022. The benefits offered by primary hip replacement procedures include improved function, pain relief, and advanced quality of life among others resulting in augmenting the segment revenue in foreseeable future. Additionally, manufacturers in the market offer a comprehensive portfolio of technologically advanced hip products coupled with a focus on specific requirements of individual patients. The notable growth rate of the segment is owing to developments in hip joint replacement surgical methods that reduce the risk of chronic health conditions and allow the removal of the diseased bone & cartilage. The surging adoption of hip replacement devices is due to the high success rate of primary hip replacement surgery.
 

Increasing preference for metal-on-plastic hip replacement devices will positively impact the industry landscape

Based on material, the hip replacement market is classified into metal-on-plastic, ceramic-on-plastic, ceramic-on-ceramic, and others. The metal-on-plastic segment accounted for more than USD 4.22 billion in 2022. The significant revenue share is owing to the advantages metal-on-plastic devices offer that includes durability, precise outcome, affordable alternative, etc. Metal-on-plastic hip replacement devices are a better alternative for less active patients and are the most regularly used hip replacement implants. Furthermore, several other benefits such as technological advancements, fewer complications, and lesser wear particles are increasing its adoption. The most used metal and plastic include stainless steel & titanium and polyethylene, respectively. It is the widely used artificial hip component material chosen by surgeons owing to its advantages. For instance, as per the recent research article, metal-on-plastic hip implant may advance hip resurfacing results and offer good long-term outcomes in aged patients.
 

Benefits of cemented fixation in high survival rate of implant will spur the business expansion

Hip replacement market from cemented fixation segment is anticipated to reach over USD  762 million by 2032. This steady growth rate is due to benefits such as high survival rate, forms an interlocking fit between implant & bone, and allows the bone to grow onto the implant over time. For instance, the survival rate of cemented fixation used at 10 years is around 96% in patients aged over 75 years. Cemented fixation uses fast-drying bone cement to attach the patient's natural bone and the prosthetic joint component. A small amount of antibiotic material can be added to the bone as the cement dries within 10 minutes of application thus, helps to reduce the risk of post-surgical infection.
 

High adoption of cross-linked polyethylene inserts in hip arthroplasty will positively impact the industry analysis

Based on inserts, the hip replacement market is segmented as cross-linked polyethylene inserts, antioxidant polyethylene inserts, and non-antioxidant polyethylene inserts. The cross-linked polyethylene inserts segment is anticipated to reach over USD 3.43 billion by 2032. The advantages of cross-linked polyethylene include reduced osteolysis, offers excellent clinical outcomes, and implant survivorship among others resulting in augmenting the segment revenue in foreseeable future. These inserts are developed precisely to decrease polyethylene wear and subsequent wear debris-induced osteolysis. For instance, clinical studies have demonstrated that cross-linked polyethylene inserts have a high success rate in primary hip arthroplasty.
 

Moreover, in hip replacement procedures, this insert is comparatively insensitive to femoral head size, allows the surgeon to use large femoral heads to strengthen hip stability and decrease post-operative complications. According to the article published by the National Center for Biotechnology Information (NCBI), cross-linked polyethylene inserts have been widely adopted and are highly effective 15 years after the surgery in a young & active individual.  Hence, owing to these attributes the industry is anticipated to witness a lucrative growth in the coming years. 
 

Increasing hospitalizations with severe hip arthritis and osteoporosis will simulate the industry potential